
By developing a non-invasive blood test for endometriosis, Bowerman is attacking a diagnostic gap that forces 200 million women to wait an average of 7–10 years — and currently requires surgery — just to confirm they have the disease.
Heather Bowerman is the Founder and CEO of DotLab, a medical technology company developing a non-invasive blood test for endometriosis, a chronic disease affecting approximately 200 million women worldwide.
Bowerman founded DotLab to address one of the most significant diagnostic challenges in women's health: endometriosis is notoriously difficult to diagnose, with an average delay of 7-10 years from symptom onset to diagnosis, and definitive diagnosis currently requires surgical laparoscopy. DotLab's non-invasive test could dramatically reduce diagnostic delays, enabling earlier treatment and better outcomes for millions of women suffering from this painful condition. Bowerman holds degrees from UC Berkeley and Stanford Graduate School of Business, and was named to Forbes' 30 Under 30 for healthcare. She has spoken at major conferences including the World Economic Forum and has been featured in major publications as a pioneer in women's health diagnostics. Her work addresses a massive unmet medical need that has been systematically underfunded and understudied for decades-representing both significant commercial opportunity and meaningful public health impact.

An invitation, extended to Powered readers.